Objective. To estimate incidence and prevalence rates of rheumatoid arthritis (RA) in the city
of Buenos Aires (CABA), Argentina, using data from a university hospital–based health …

Health registries are organized systems that collect data on individuals with a particular
disease, condition or exposure. The aim of this narrative review was to provide an integrated …

… In stage 1 (dose finding), 124 patients who responded to rituximab induction were randomly
assigned to SC rituximab (375 mg/m2, 625 mg/m2, or an additional group at 800 mg/m2) or …

… duration of 10 days at a dose of ≤100 mg per day) was allowed to treat symptoms in …
reduction was to 1·0 mg/m 2 , and subsequently, if necessary, to 0·7 mg/m 2 . Doses of less than 0·7 …

… ⩾1 dose of rituximab IV as maintenance received a single dose of rituximab 375 mg m −2
IV, 375 mg m −2 SC, 625 mg m −2 SC, or 800 mg m −2 SC, with subsequent IV doses (375 …

… of 9 mg per square meter of body-surface area) and prednisone (at a dose of 60 mg per
square meter) on days 1 to 4, either alone or with bortezomib (at a dose of 1.3 mg per square …

… /m 2 in patients who achieved a PR, and 15.6 mg/m 2 in patients with no response (… mg/m
2 in patients who achieved a CR, 15.5 mg/m 2 in patients who achieved a PR, and 17.8 mg/m 2 …

… (750 mg/m 2 ), doxorubicin (50 mg/m 2 ), and vincristine (1·4 mg/m 2 , with a maximum total
dose of 2 mg), all … (100 mg) administered on days 1–5. Rituximab was given at a dose of 375 …

Survival of adults with acute lymphoblastic leukemia (ALL) is inferior to that of pediatric patients.
Strategies to improve the outcome of adult population are warranted. This study aims to …

… and peritoneal dialysis populations, both the KDOQI guidelines and EBPGs do not specify
the recommended method of iron supplementation, but recommend at least 100 to 200 mg/d …